Clinical Trial Update: The Effect of Prostaglandin I2 on the Endothelial Cell Function Disorder in Type 2 Diabetes Mellitus Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effect of prostaglandin I2 on endothelial cell function in Type 2 diabetes mellitus patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Prostaglandin I2 (prostacyclin (PGI2))

Snippet

Sponsor: Yonsei University | Conditions: Type 2 Diabetes Mellitus, Peripheral Microvascular Symptoms | Phase 4 | Status: COMPLETED